HORIZON-MISS-2024-CANCER-01-05
HORIZON-MISS-2024-CANCER-01-05
Programme: Horizon Europe
5 projects · €30,341,782 total EU contribution (project-level) · 92 participating organizations · 23 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€30,341,782
Countries active
Participant organizations by country (headquarters in CORDIS).
- Italy (13)
- Spain (11)
- Netherlands (9)
- France (7)
- Germany (6)
- UK (6)
- IE (5)
- BE (4)
- EL (4)
- CH (3)
- LT (3)
- PT (3)
- SE (3)
- EE (2)
- FI (2)
- HR (2)
- NO (2)
- RO (2)
- AT (1)
- CZ (1)
- DK (1)
- PL (1)
- SK (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- INT3 projects · IT
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN2 projects · NL
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN2 projects · DE
- E.C.O.2 projects · BE
- NATIONAL CANCER INSTITUTE2 projects · LT
- RS2 projects · SE
- NKI AVL2 projects · NL
- UNIVLEEDS2 projects · UK
- CETEM1 projects · ES
- CENTRE FOR INNOVATION IN MEDICINE1 projects · RO
- ECL ASSOCIATION OF EUROPEAN CANCER LEAGUES1 projects · BE
- C QUADRA SRL1 projects · IT
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Co-creation and implementation of an intervention to improve the understanding of TesticulaR cANcer late effects and unmet Supportive CarENeeDs of AYA survivors using eXtended Reality. TRANSCEND-XR · 101214413 | HORIZON | €6,003,930 | €149,000 | Details |
Patient-centred, evidence-based late effect screening and follow-up care of survivors of adolescent and young adult cancer PanCare4AYA · 101213107 | HORIZON | €5,770,234 | €0 | Details |
smart Mirrors supporting healthier lives of Adolescents and Young Adults after cancer MAYA · 101213323 | HORIZON | €5,998,796 | €542,625 | Details |
Prediction and prevention of late effects in AYA cancer survivors – An effort to understand, predict and prevent late effects in AYAs 15-39 years of age, with a focus on fertility and gonadal toxicity PredictAYA · 101214879 | HORIZON | €6,329,134 | €326,095 | Details |
Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach LATE-AYA · 101214326 | HORIZON | €6,239,688 | €746,250 | Details |